Letters Breast cancer screening debate

Independent UK Panel on Breast Cancer Screening replies to Michael Baum

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f873 (Published 13 February 2013) Cite this as: BMJ 2013;346:f873
  1. Michael Marmot, director1
  2. Independent UK Panel on Breast Cancer Screening: D G Altman (University of Oxford), D A Cameron (University of Edinburgh), J A Dewar (University of Dundee), S G Thompson (University of Cambridge), Maggie Wilcox (patient advocate).
  1. 1UCL Institute of Health Equity, UCL Dept of Epidemiology and Public Health, London WC1E 7HB, UK
  1. m.marmot{at}ucl.ac.uk

Baum has raised interesting and important issues.1 The panel did not “duck” the effect of breast screening on all cause mortality. We indicated in the full report (p 32) that a 20% reduction in breast cancer mortality would reduce mortality from all cancers by only 3% and all cause mortality by 1.2%.2 The randomised trials performed lacked …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe